Advarra Executive and Leadership Team

Gadi Saarony, the Chief Executive Officer at Advarra, directs the overarching strategy and vision for the organization. Saarony guides Advarra's mission to advance clinical research by fostering collaboration between life sciences companies, research sites, and academic institutions. This leadership role involves ensuring Advarra's integrated solutions effectively safeguard trial participants and optimize research performance across the industry. By focusing on the intersection of safety, technology, and collaboration, Gadi Saarony drives the company's commitment to making clinical trials safer, smarter, and faster. The Chief Executive Officer's strategic direction ensures Advarra maintains its position at the forefront of clinical trial innovation and operational excellence, impacting global research standards.

Andrey Zubachev, the Joint Chief Executive Officer at Advarra, shares executive leadership responsibilities, focusing on specific strategic imperatives and operational execution. Zubachev collaborates with the leadership team to advance Advarra's mission of transforming clinical research conduct. This involves driving initiatives that enhance the integration of technology and collaboration across the clinical trial ecosystem. Andrey Zubachev's focus includes optimizing Advarra's service offerings to ensure robust participant safety, site empowerment, and regulatory compliance. The Joint Chief Executive Officer's efforts are critical in realizing Advarra's goal of making clinical trials more efficient and effective, contributing significantly to the company's market impact and innovation pipeline.

Dwight Van Inwegen, the Chief Financial Officer at Advarra, directs all financial operations and strategic financial planning for the organization. Van Inwegen manages the fiscal health of Advarra, ensuring resources are allocated effectively to support the company's mission of advancing clinical research. This role involves overseeing budgeting, forecasting, and financial reporting to drive sustainable growth and operational efficiency. Dwight Van Inwegen's financial acumen is crucial for supporting Advarra's integrated solutions that enhance safety, technology, and collaboration across the clinical trial landscape. The Chief Financial Officer's leadership ensures Advarra maintains a strong financial foundation to continue innovating and making clinical trials safer, smarter, and faster.

Scott Uebele, the Chief Operating Officer at Advarra, oversees the day-to-day operational functions and ensures the efficient delivery of Advarra's integrated solutions. Uebele manages the operational infrastructure that supports Advarra's mission to advance clinical research, focusing on optimizing performance and safeguarding trial participants. This leadership position involves streamlining processes across research sites, life sciences companies, and academic institutions to enhance collaboration and technology integration. Scott Uebele's responsibilities include driving operational excellence to ensure compliance and empower clinical sites effectively. The Chief Operating Officer's strategic oversight guarantees that Advarra's services are delivered with maximum impact, contributing directly to making clinical trials safer, smarter, and faster.

Allie Rozanski, the Chief Revenue Officer & Client Executive at Advarra, spearheads revenue generation and manages key client relationships across the life sciences sector. Rozanski drives commercial strategy, focusing on expanding Advarra's market reach and ensuring client success with its integrated solutions. This dual role involves cultivating strong partnerships with research sites, investigators, and academic institutions to foster collaboration and technology adoption. Allie Rozanski's leadership ensures Advarra's offerings effectively safeguard trial participants and optimize research performance. The Chief Revenue Officer & Client Executive's dedication to client satisfaction and revenue growth is instrumental in advancing Advarra's goal of making clinical trials safer, smarter, and faster.